Pancreatic endocrine tumor in Japan.
Japanese clinicians and scientists have contributed significantly to reporting, investigating, and managing patients with pancreatic endocrine tumors and other multiple endocrine neoplasias for the past several decades. This article summarizes the latest progress in this field in Japan. Particularly, our contribution to the development of diagnostic and localization methods is reviewed. Further, the present use of somatostatin receptor scintigraphy and the application of the laparoscopic surgery for pancreatic endocrine tumor in Japan are discussed.
Doi
Ryuichiro
R
Department of Surgery and Surgical Basic Science, Kyoto University, Kyoto, Japan. doir@kuhp.kyoto-u.ac.jp
Komoto
Izumi
I
Nakamura
Yoshio
Y
Kawamura
Junichiro
J
Fujimoto
Koji
K
Wada
Michihiko
M
Saga
Tsuneo
T
Imamura
Masayuki
M
D002118:Calcium / Q000008:administration & dosage; D015408:Gastrinoma / Q000175:diagnosis; D005755:Gastrins / Q000097:blood; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007340:Insulinoma / Q000175:diagnosis; D007564:Japan; D010535:Laparoscopy; D010179:Pancreas / Q000098:blood supply; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000601:surgery; D017481:Receptors, Somatostatin / Q000032:analysis; D012633:Secretin / Q000008:administration & dosage; D015043:Zollinger-Ellison Syndrome / Q000175:diagnosis
D005755:Gastrins; D017481:Receptors, Somatostatin; D012633:Secretin; D002118:Calcium